Web Results

res.cloudinary.com/lbresearch/image/upload/v1396896076/Eisai_v_Sanofi_3_28_Opinion_Unsealed_nbzekj.pdf

Mar 28, 2014 ... EISAI INC.,. Plaintiff, v. SANOFI-AVENTIS U.S., LLC, et al.,. Defendants. CIVIL ACTION NO. 08-4168 (MLC). MEMORANDUM OPINION. COOPER, District Judge ... marketed in the United States by Sanofi, and Fragmin®, marketed in. 1 ...... motion to exclude the testimony of Tony Casanova, Stephen Melvin,.

www.ncbi.nlm.nih.gov/pubmed/17107991

Nov 15, 2006 ... Casanova C(1), Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L, Celli BR. Author information: (1)Respiratory Research Institute, Universidad de La Laguna, Tenerife, Spain. ccasanova@canarias.org. The 6-min walking distance (6MWD) test is used in clinical practice and research ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4610793

Oct 15, 2015 ... Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus ..... Bannuru et al26 have recently explored this issue and reported that IA HA had the largest effect size of any intervention examined versus oral placebo.

blogs.harvard.edu/billofhealth/2017/06/22/vaccine-liability-in-europe-a-new-development

Jun 22, 2017 ... By Alex Stein. Yesterday, the European Court of Justice has issued an important ruling on vaccine manufacturers liability. N.W. et al. v. Sanofi Pasteur MSD, C‑ 621/15. This ruling triggered a hailstorm of criticism from different media outlets, including CNN. These outlets, however, have largely misreported ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0098587

Jun 18, 2014 ... Casanova R, Whitlow CT, Wagner B, Williamson J, Shumaker SA, et al.. (2011) High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. Frontiers of Neuroscience in Neuroinformatics 5: 22 . Epub 2011 Oct 14. 26. Casanova R, Maldjian JA, Espeland MA ...

www.sciencedirect.com/science/article/pii/S2215001316300257

Overall, cognition accounts for 20–60% of the variance in patients' functional outcomes across studies (Galderisi et al., 2014; Velligan et al., 1997; Zaragoza .... 2001; Casals-Coll et al., 2013; Pena-Casanova et al., 2009), with age as the only stratification variable (CFT-Animals) and age and years of education for the other  ...

www.pnas.org/content/112/51/15533.full

Dec 22, 2015 ... Six years later, Casanova laid bare the genetic basis of Devainon's immune deficiency in punctilious detail. The findings, which eventually led to a career spurt for Casanova, now an immunologist at the Rockefeller University in New York City, exemplify his insights on inborn errors of immunity. For these ...

www.nature.com/articles/s41533-017-0013-2

Feb 15, 2017 ... In Sweden, COPD mortality in women increased between 1999–2009, and life expectancy among COPD patients was 9.4 years lower in women (vs. 7.4 years lower in men) ..... de Torres, J. P., Casanova, C., Hernandez, C., Abreu, J., Montejo de Garcini, A. & Aguirre-Jaime, A. et al. Gender associated ...

jem.rupress.org/content/early/2013/07/23/jem.20130592

Jul 29, 2013 ... The observation that some children with isolated, classic KS were born to consanguineous parents further suggested that single-gene inborn errors of immunity might underlie such cases (Sahin et al., 2010), as seen in children with other isolated life-threatening infectious diseases (Casanova and Abel, ...